Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report

The inhibition of invasion of human melanoma cells through N-cadherin knock-down

(2018) Dorota Ciołczyk-Wierzbicka et al.   MEDICAL ONCOLOGY

Gynecologic melanomas: A clinicopathologic and molecular analysis

(2017) Aaron M. Udager et al.   GYNECOLOGIC ONCOLOGY

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

(2017) Sandra P. D’Angelo et al.   JOURNAL OF CLINICAL ONCOLOGY

Repurposing itraconazole as an anticancer agent

(2017) Hiroshi Tsubamoto et al.   Oncology Letters

Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion

(2017) Linda Ziani et al.   Oncotarget

Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways

(2017) Guanzhao Liang et al.   Oncotarget

Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and Angiogenesis

(2016) Sarah A. Head et al.   ACS Chemical Biology

Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma

(2016) June Y. Hou et al.   CANCER

Evidence and Clinical Relevance of Tumor Flare in Patients Who Discontinue Tyrosine Kinase Inhibitors for Treatment of Metastatic Renal Cell Carcinoma

(2015) Roberto Iacovelli et al.   EUROPEAN UROLOGY

Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma

(2015) Linli Zhou et al.   Journal of Cancer

Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma

(2014) Daniel J. Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma

(2013) R Plummer et al.   BRITISH JOURNAL OF CANCER

E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression

(2013) J. Lade-Keller et al.   BRITISH JOURNAL OF DERMATOLOGY

Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer

(2013) Charles M. Rudin et al.   Journal of Thoracic Oncology

Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer

(2013) E. S. Antonarakis et al.   ONCOLOGIST

Primary Malignant Melanoma of the Vagina

(2010) Michael Frumovitz et al.   OBSTETRICS AND GYNECOLOGY

The reverse side of the victory: Flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases

(2009) Ingrid M. E. Desar et al.   ACTA ONCOLOGICA

Validation of serum biomarkers for detection of early- and late-stage endometrial cancer

(2009) Gina Farias-Eisner et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: Association to tumor derived alpha-N-acetylgalactosaminidase activity

(2009) Marilena Greco et al.   CANCER LETTERS

Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma

(2009) Tim Eisen et al.   MELANOMA RESEARCH

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER